Ischemic Heart Disease Clinical Trial
Official title:
Vegetarian Diet in Patients With Ischemic Heart Disease: An Open-label, Randomized, Prospective Crossover Study
Open label, 4 week randomized, cross-over study to compare the effect of a vegetarian diet to a conventional (meat containing) diet based on the Swedish average meat consumption on a range of parameters with prognostic importance for cardiovascular disease.The study will be conducted in patients diagnosed with ischemic heart disease. We hypothesize that patients will benefit from a vegetarian diet as assessed by multiple risk markers for this type of disease with a primary focus on changes in oxidized LDL cholesterol.
Background
Cardiovascular disease is the leading cause of death globally. Ischemic heart disease (IHD)
contributes the most to this statistic and since 1990 the global burden of IHD has increased.
It is estimated that 50 000 Swedish patients are hospitalized every year due to IHD. The risk
of developing IHD is to a large extent determined by the existence and state of several
modifiable risk factors including dietary habits, smoking, hypertension, diabetes mellitus,
hyperlipidemia, high apolipoprotein B/ apolipoprotein A1-ratio, abdominal obesity, physical
inactivity, alcohol consumption and psychosocial factors. High levels of oxidative stress,
oxidized LDL cholesterol and the microbial metabolite trimethylamine N-oxide TMAO have been
suggested to be associated with development of IHD.
A plant-based (vegetarian) diet may provide cardiovascular health benefits through various
mechanisms. Clinical studies suggest that a vegetarian diet has positive effects on
low-density lipoprotein (LDL) cholesterol, oxidized LDL cholesterol, total cholesterol,
triglycerides, apolipoprotein B, body mass index (BMI), inflammatory markers, blood pressure,
arterial intima-media thickness, insulin sensitivity, glycated hemoglobin, (HbA1c) and
fasting glucose levels. Through positive impacts on risk factors that a vegetarian diet is
associated with a lowered incidence and mortality of IHD and an overall reduced mortality.
A weakness of several prior long-term controlled studies comparing vegetarian and
meat-containing diets is the lack of well-defined control diets leading to study
heterogeneity. For example, some of the subjects on meat-containing diets consume great
quantities of red meat, others eat substantial amounts of processed meat products and some
eat mostly white meat and fish complicating interpretation of outcome. In cross-sectional or
observational cohort studies comparing long-term vegetarians to long-term omnivores, results
may be influenced by other lifestyle choices besides the studied diet, such as smoking and
exercise.Furthermore, the participants in many previous studies were often healthy volunteers
and not patients with overt cardiovascular disease.
Purpose
The objective is to perform an open label, 4 week randomized, cross-over study to compare the
effect of a vegetarian diet to a conventional (meat containing) diet based on the Swedish
average meat consumption on a range of parameters with prognostic importance for
cardiovascular disease: lipids, inflammation, oxidative stress, BMI, HbA1c, apolipoprotein
B/apolipoprotein A1-ratio, gut microbiota, endothelial function and quality of life. The
study will be conducted in patients diagnosed with STEMI (ST-segment elevation myocardial
infarction), non-STEMI (non-ST-segment elevation myocardial infarction) or angina pectoris
and treated by percutaneous coronary intervention (PCI).
Hypothesis
The study hypothesis is that patients diagnosed with IHD can benefit from a vegetarian diet
as assessed by multiple risk markers for this type of disease with a primary focus on changes
in oxidized LDL cholesterol.
Clinical relevance
During the last decades the global mortality from IHD has remained unchanged regardless of
development of new invasive and pharmacological treatments. Despite the fact that the
prevalence and mortality from IHD have decreased in this country since 1990 and that the
decrease most likely is due to lifestyle changes, IHD remains the leading cause of death in
Sweden.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Active, not recruiting |
NCT04562805 -
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
|
N/A | |
Recruiting |
NCT05292079 -
CAPTURER PMCF Study ( rEPIC04D )
|
||
Recruiting |
NCT05292118 -
Navitian PMCF Study ( rEPIC04C )
|
||
Recruiting |
NCT05292092 -
Essential Pro PMCF Study ( rEPIC04E )
|
||
Recruiting |
NCT05292014 -
ANGIOLITE PMCF Study ( rEPIC04F )
|
||
Completed |
NCT05292105 -
NC Xperience PMCF Study( rEPIC04B)
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Not yet recruiting |
NCT04153383 -
Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery
|
||
Recruiting |
NCT02982434 -
The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
|
Phase 2 | |
Recruiting |
NCT02729064 -
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
|
Phase 1 | |
Completed |
NCT02468401 -
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
|
N/A | |
Completed |
NCT02759406 -
Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study
|
N/A | |
Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
Completed |
NCT01699802 -
Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)
|
N/A | |
Completed |
NCT01604213 -
Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
Completed |
NCT01724567 -
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training
|
N/A | |
Completed |
NCT02159235 -
Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)
|
N/A |